Carla Magda Allan Santos Domingues

ORCID: 0000-0003-1463-4939
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Vaccine Coverage and Hesitancy
  • COVID-19 Impact on Reproduction
  • Global Maternal and Child Health
  • Virology and Viral Diseases
  • SARS-CoV-2 and COVID-19 Research
  • Respiratory viral infections research
  • Mosquito-borne diseases and control
  • Cervical Cancer and HPV Research
  • Maternal and Neonatal Healthcare
  • Viral Infections and Outbreaks Research
  • Hepatitis B Virus Studies
  • Ethics and Legal Issues in Pediatric Healthcare
  • Viral gastroenteritis research and epidemiology
  • Food Security and Health in Diverse Populations
  • Pneumonia and Respiratory Infections
  • Immune responses and vaccinations
  • vaccines and immunoinformatics approaches
  • Influenza Virus Research Studies
  • COVID-19 Clinical Research Studies
  • Syphilis Diagnosis and Treatment
  • Adolescent Sexual and Reproductive Health
  • Public Health in Brazil
  • Hepatitis Viruses Studies and Epidemiology
  • Misinformation and Its Impacts
  • Pneumocystis jirovecii pneumonia detection and treatment

Pan American Health Organization (Brasil)
2022-2025

Elabora Consultoria (Brazil)
2022-2025

Pan American Health Organization (Cuba)
2023

Universidade de Brasília
2004-2022

Ministério da Saúde
2012-2021

Brazilian Society of Tropical Medicine
2012-2021

Ministério da Saúde
2014-2020

Secretaria da Saúde
2015-2019

National Center for Immunization and Respiratory Diseases
2015-2019

Instituto de Medicina Tropical
2016

Resumo: O Programa Nacional de Imunizações (PNI), coordenado pelo Ministério da Saúde, forma compartilhada com as secretarias estaduais e municipais saúde, vem se consolidando como uma das principais mais relevantes intervenções em saúde pública, a conquista resultados importantes, certificação área livre circulação do poliovírus selvagem, eliminação vírus rubéola importante impacto na redução dos casos mortes pelas doenças imunopreveníveis, partir sua criação 1973. Brasil é um países que...

10.1590/0102-311x00222919 article PT cc-by Cadernos de Saúde Pública 2020-01-01

Objective: to describe vaccination coverage (VC) and its homogeneity, dropout rates (DR) the occurrence of vaccine-preventable diseases in Brazil. Methods: a descriptive cross-sectional study was conducted based on National Immunization Program (PNI) information systems data for period 2002-2012 order calculate VC, homogeneity DR indicators, also provided by Ministry Health’s Communicable Diseases Coordination sector 1982-2011 disease incidence. Results: VC high both routine campaigns,...

10.5123/s1679-49742013000100002 article EN cc-by-nc Epidemiologia e Serviços de Saúde 2013-03-01

Pneumonia is most problematic for children in developing countries. In 2010, Brazil introduced a 10-valent pneumococcal conjugate vaccine (PCV10) to its National Immunization Program. To assess the vaccine's effectiveness preventing pneumonia, we analyzed rates of hospitalization among 2-24 months age who had pneumonia from all causes January 2005 through August 2011. We used data Hospitalization Information System conduct an interrupted time-series analysis 5 cities that good quality and...

10.3201/eid1904.121198 article EN cc-by Emerging infectious diseases 2013-03-04

This paper reflects on the vaccination campaign against COVID-19 in Brazil light of consideration scientific evidence decision-making process. has one largest and most complete programs world, National Immunization Program (Programa Nacional de Imunizações or PNI). Unfortunately, current context, with political interference federal government, PNI lost its role conducting COVID-19. Despite being a lot potential accepted by population among countries it presented many problems left several...

10.1590/1413-81232022273.21822021 article PT Ciência & Saúde Coletiva 2022-03-01

As of September 2022, nearly 1.3 billion doses COVID-19 vaccine products have been administered in Latin America and the Caribbean, where 27% global deaths occurred. This study aimed to estimate effectiveness vaccines against lab-confirmed related hospitalizations among adults Argentina, Brazil, Chile, Colombia.Using a test-negative case control design, we evaluated primary vaccination series considering six (Sputnik V, mRNA-1273, CoronaVac, ChAdOx1, BNT162b2, Ad26.COV2.S) 83,708...

10.1016/j.lana.2023.100474 article EN cc-by-nc-nd The Lancet Regional Health - Americas 2023-03-29

In addition to screening by Pap smears, vaccination against human papillomavirus (HPV) can dramatically reduce cervical cancers caused the virus. The acceptance of HPV is directly related knowledge. This research aimed evaluate knowledge about and among men women aged 16–25 years who use public health system in Brazil. was a cross-sectional, multicenter study sexually active young adults recruited from 119 primary care units between 2016 2017. All participants answered face-to-face...

10.1016/j.pvr.2019.03.003 article EN cc-by-nc-nd Papillomavirus Research 2019-03-16

Abstract For Brazil, there are no nationwide data on HPV prevalence against which the impact of immunization program can be measured in future. Therefore, we aim to evaluate genital infection among adolescents and young adults Brazil. A cross-sectional, multicentric, survey was conducted between September 2016 November 2017. Sexually active unvaccinated women men aged 16 25 years old were recruited from 119 public primary care units, including all 26 state capitals Federal District. All...

10.1038/s41598-020-61582-2 article EN cc-by Scientific Reports 2020-03-18

The vaccine is one of the main control measures available for a major portion infectious and transmissible diseases.It stands out as great discoveries public health benefit population.In Brazil, more than two centuries have passed since first time (1804) was administered measure to prevent smallpox.Exactly century later (1904), an epidemic this disease led President Republic Rodrigues Alves, establish obligation vaccination.In same year, hygienist Osvaldo Cruz coordinated mass vaccination...

10.1590/s0036-46652012000700009 article EN Revista do Instituto de Medicina Tropical de São Paulo 2012-09-22

A single vaccination of Yellow Fever vaccines is believed to confer life-long protection. In this study, results vaccinees who received a dose 17DD-YF immunization followed over 10 y challenge premise. YF-neutralizing antibodies, subsets memory T and B cells as well cytokine-producing lymphocytes were evaluated in groups adults before (NVday0) after (PVday30-45, PVyear1-4, PVyear5-9, PVyear10-11, PVyear12-13) primary vaccination. antibodies decrease significantly from PVyear1-4 PVyear12-13...

10.1080/21645515.2015.1082693 article EN cc-by-nc Human Vaccines & Immunotherapeutics 2015-09-11

Ten-valent pneumococcal conjugate vaccine (PCV10) was introduced in the National Immunization Program of Brazil March/2010. Although there are recent reports PCV10 impact on pneumonia hospitalizations, is still uncertainty regarding indirect individuals non-targeted by vaccination. We assessed both direct and effect hospitalizations economic burden hospitalizations.An interrupted time-series analysis conducted considering monthly rates comparison groups, all age-groups, from...

10.1371/journal.pone.0184204 article EN cc-by PLoS ONE 2017-09-07

To evaluate opportunity for vaccination in children born alive Londrina, up to 6 months old and the relationship between socioeconomic stratum regularity. Population survey study based on a retrospective cohort of 2017 2018 that identified vaccines not administered given session. Vaccination regularity was compared strata using Pearson's chi-square test. Out 456 cards, proportion opportunities recovered doses be at birth two, four six 5.0% (95%CI 3.1;7.5), 4. 5% 2.8;6.9), 7.2% 5.0;10.2) 2.1%...

10.1590/s2237-96222024v33e2024432.especial2.en article EN PubMed 2025-01-01

To estimate and compare vaccination coverage among children born in 2017-2018 São Paulo Campinas, according to the Vaccination Coverage Survey (ICV 2020) National Immunization Program Information System (SI-PNI). ICV 2020 analyzed card records. was calculated compared doses recorded on SI-PNI, divided by target population. In Paulo, ICV, 2017 only BCG (91.7%; 95%CI 87.0;94.7) rotavirus first dose (90.6%; 86.5;93.5) achieved goals; 2018, (93.4%; 89.5;95.8), (90.5%; 85.3;94.0), pneumococcal...

10.1590/s2237-96222024v33e2023539.especial2.en article EN PubMed 2025-01-01

To estimate prevalence of the full vaccination schedule for children 12 to 24 months old and analyze associated factors. Survey with cluster sampling carried out in Vitória, Espírito Santo, Brazil, between December 16, 2020, January 4, 2021. Children born Vitória 2017 2018 were included. We estimated schedules. Poisson regression was used verify association coverage. included 788 children. Full coverage found be 57% taking a 95% confidence interval (95%CI 50.98;62.98). Prevalence lowest when...

10.1590/s2237-96222024v33e20231195.especial2.en article EN PubMed 2025-01-01

To analyze vaccination coverage and factors associated with incomplete in inland municipalities of Northeastern Brazil. This was a household survey using cluster sampling conducted Vitória da Conquista, Bahia state, Caruaru, Pernambuco Sobral, Ceará state Imperatriz, Maranhão between 2020 2022. Vaccination by valid doses vaccine hesitancy were analyzed, the odds ratio (OR) estimated adjusted logistic regression. Among 1,847 children, complete 49.2% (95%CI 43.9;54.5). Factors included: higher...

10.1590/s2237-96222024v33e20231224.especial2.en article EN PubMed 2025-01-01

To analyze vaccine hesitancy associated factors and repercussions on vaccination coverage. Cohort of children born in 2017-2018, living Brazilian state capitals, Federal District (FD), 12 inner region cities, stratified by socioeconomic level. National Vaccination Coverage Survey (2020) data hesitancy, access programmatic difficulties were obtained interview coverage was calculated from card dose date records. 37801 studied, 31001 the capitals/FD, 6800 cities. Hesitation between 38.8(95%CI...

10.1590/s2237-96222024v33e20231097.especial2.en article EN PubMed 2025-01-01

To estimate vaccination coverage and analyze factors associated with full among children up to 15 months old in the city of Natal-RN, Brazil. Population-based survey data recorded on children's cards interviews conducted 2020 2021. Analysis complete was performed by calculating prevalence ratios (PR) 95% confidence intervals (95%CI) using Poisson regression. Among 688 studied, 45.4% (95%CI 37.2;53.9) 15.5% 10.6;22.2) for valid on-time doses, respectively. Higher females (PR=1.08; 95%CI...

10.1590/s2237-96222024v33e20231307.especial2.en article EN PubMed 2025-01-01

to describe the transmission risk classification of vaccine-preventable diseases in Brazilian municipalities.this was a descriptive epidemiologic study using 2014 data National Immunization Program Information System; vaccine coverage indicators were used classify municipalities.of 5,570 municipalities, 12.0% classified as very low risk, 29.6% 2.2% medium 54.3% high and 1.8% risk.the vaccination surveillance allowed identify most municipalities situation minority children living with...

10.5123/s1679-49742016000400008 article EN cc-by-nc Epidemiologia e Serviços de Saúde 2016-10-01
Coming Soon ...